手术和慢性胰腺炎

IF 2.8 3区 医学 Q2 SURGERY Surgical Clinics of North America Pub Date : 2001-04-01 Epub Date: 2005-07-15 DOI:10.1016/S0039-6109(05)70131-6
Avram M. Cooperman MD
{"title":"手术和慢性胰腺炎","authors":"Avram M. Cooperman MD","doi":"10.1016/S0039-6109(05)70131-6","DOIUrl":null,"url":null,"abstract":"<div><div><span>Chronic pancreatitis<span> is characterized by irreversible and continued destruction of pancreatic acinar and duct cells. These cells are replaced by fibrous tissue and deposition of extracellular matrix.</span></span><span><span><sup>15</sup></span></span><span><span> Chronic pancreatitis is a spectrum of a disease that ranges from mild, with occasional attacks; to moderate, with frequent attacks and more irreversible glandular changes; to severe, with disabling </span>sequelae<span><span>, such as intractable pain, diabetes, and </span>pancreatic insufficiency </span></span><span><span>(Fig. 1)</span></span><span><span>. Until recently, surgeons were referred only patients with severe chronic pancreatitis who were malnourished, often abusers of alcohol or narcotics, and who had end-stage glandular disease. Pancreatic function<span> did not improve after surgery, and improvement of pain and diminished frequency and severity of attacks were the sole determinant of a successful surgical procedure. Much has changed in the past decade. Today, earlier diagnosis of chronic pancreatitis by </span></span>endoscopy and axial imaging and intervention for mild symptoms may delay the progressive changes in secretory function and exocrine and endocrine malfunction.</span><span><span>40</span></span>, <span><span>42</span></span></div><div>Objective complications of chronic pancreatitis warrant surgery; however, at present, these account for a minority of the procedures used to treat chronic pancreatitis. In contrast, the most common indications for surgery are the subjective complaints of intractability, interference with lifestyle, and pain. These issues create a dilemma in the selection of procedures and patients for treatment, akin to deciding jury awards for pain and suffering. In both, it is difficult to reach a wise judgment or a happy outcome.</div><div>This article reviews the current surgical treatment of chronic pancreatitis. Lessons learned from a 25-year experience are included to caution surgeons that unbridled enthusiasm is best replaced by tempered judgments.</div><div>The prevalence of chronic pancreatitis (as with pancreatic cancer) is low, at 8 to 10 cases per 100,000 population. Long-term consumption of alcohol is the cause of the disease in 75% of patients worldwide. Primary duct obstruction as a cause of chronic pancreatitis is present in only 5% of patients.<span><span><sup>42</sup></span></span><span> Depending on hospital population and surgical referral practice, the causes of pancreatitis vary widely. Idiopathic pancreatitis, a diagnosis of exclusion, is more common in tertiary centers than in urban hospitals and accounts for nearly 40% of the cases referred to the author's institution. The cause of chronic pancreatitis is important only in preventing ongoing glandular insult by removing an exogenous stimulus, if identified. The choice of surgical procedure is dependent on anatomic findings and not on the cause.</span></div><div><span><span><span>Complications of chronic pancreatitis occur secondary to healing and fibrosis of the pancreas or deposition of inspissated proteinaceous material in the pancreatic duct, leading to duct obstruction and calculi. Tissue samples from patients undergoing pancreatic resection for chronic pancreatitis demonstrate an increased tissue level of </span>connective tissue growth factor (CTGF; 25-fold) and </span>transforming growth factor (TGF-B</span><sub>1</sub>; increased in 50% of chronic pancreatitis tissue samples). CTGF is a cysteine-rich peptide that belongs to a family of genes needed for the coordination of tissue repair.<span><span><sup>15</sup></span></span> The overexpression of CTGF and TGF-B<sub>1</sub> in chronic pancreatitis suggests that these proteins may contribute to the enhanced extracellular matrix synthesis, leading to fibrin and collagen deposition in chronic pancreatitis.<span><span><sup>15</sup></span></span><span> As a result of pancreatic fibrosis, complications that develop include:\n\t\t\t\t</span><ul><li><span></span><span><div><div><span>Bile duct obstruction (from cicatrix or a mass in the head of the pancreas)</span></div><figure><span><img><ol><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span><span><span><p><span>Figure 4</span>. <!-->An endoscopic retrograde cholangiopancreatography (ERCP) showing a dilated bile duct (BD) and pancreatic duct (PD).</p></span></span></figure><figure><span><img><ol><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span><span><span><p><span>Figure 5</span>. <!-->The author's approach to all pancreatic surgery begins with an upper midline incision. The incision in this case was 3 inches long. (See also Color Plate 1, <span><span>Fig. 1.)</span></span></p></span></span></figure></div></span></li><li><span></span><span><div>Duodenal obstruction (from extrinsic compression of a fibrosed pancreas)</div></span></li><li><span></span><span><div><span>Gastric varices (from </span>splenic vein entrapment and obstruction)</div></span></li><li><span></span><span><div>Obstruction of the pancreatic duct (from calculi, fibrotic parenchymal strictures, or duct strictures)</div></span></li><li><span></span><span><div>Pancreatic ascites (from a leaking pancreatic duct or pseudocyst)</div></span></li><li><span></span><span><div>Pancreatic pseudocyst formation (discussed elsewhere in this issue)</div></span></li></ul></div></div>","PeriodicalId":54441,"journal":{"name":"Surgical Clinics of North America","volume":"81 2","pages":"Pages 431-455"},"PeriodicalIF":2.8000,"publicationDate":"2001-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Surgery and Chronic Pancreatitis\",\"authors\":\"Avram M. Cooperman MD\",\"doi\":\"10.1016/S0039-6109(05)70131-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><span>Chronic pancreatitis<span> is characterized by irreversible and continued destruction of pancreatic acinar and duct cells. These cells are replaced by fibrous tissue and deposition of extracellular matrix.</span></span><span><span><sup>15</sup></span></span><span><span> Chronic pancreatitis is a spectrum of a disease that ranges from mild, with occasional attacks; to moderate, with frequent attacks and more irreversible glandular changes; to severe, with disabling </span>sequelae<span><span>, such as intractable pain, diabetes, and </span>pancreatic insufficiency </span></span><span><span>(Fig. 1)</span></span><span><span>. Until recently, surgeons were referred only patients with severe chronic pancreatitis who were malnourished, often abusers of alcohol or narcotics, and who had end-stage glandular disease. Pancreatic function<span> did not improve after surgery, and improvement of pain and diminished frequency and severity of attacks were the sole determinant of a successful surgical procedure. Much has changed in the past decade. Today, earlier diagnosis of chronic pancreatitis by </span></span>endoscopy and axial imaging and intervention for mild symptoms may delay the progressive changes in secretory function and exocrine and endocrine malfunction.</span><span><span>40</span></span>, <span><span>42</span></span></div><div>Objective complications of chronic pancreatitis warrant surgery; however, at present, these account for a minority of the procedures used to treat chronic pancreatitis. In contrast, the most common indications for surgery are the subjective complaints of intractability, interference with lifestyle, and pain. These issues create a dilemma in the selection of procedures and patients for treatment, akin to deciding jury awards for pain and suffering. In both, it is difficult to reach a wise judgment or a happy outcome.</div><div>This article reviews the current surgical treatment of chronic pancreatitis. Lessons learned from a 25-year experience are included to caution surgeons that unbridled enthusiasm is best replaced by tempered judgments.</div><div>The prevalence of chronic pancreatitis (as with pancreatic cancer) is low, at 8 to 10 cases per 100,000 population. Long-term consumption of alcohol is the cause of the disease in 75% of patients worldwide. Primary duct obstruction as a cause of chronic pancreatitis is present in only 5% of patients.<span><span><sup>42</sup></span></span><span> Depending on hospital population and surgical referral practice, the causes of pancreatitis vary widely. Idiopathic pancreatitis, a diagnosis of exclusion, is more common in tertiary centers than in urban hospitals and accounts for nearly 40% of the cases referred to the author's institution. The cause of chronic pancreatitis is important only in preventing ongoing glandular insult by removing an exogenous stimulus, if identified. The choice of surgical procedure is dependent on anatomic findings and not on the cause.</span></div><div><span><span><span>Complications of chronic pancreatitis occur secondary to healing and fibrosis of the pancreas or deposition of inspissated proteinaceous material in the pancreatic duct, leading to duct obstruction and calculi. Tissue samples from patients undergoing pancreatic resection for chronic pancreatitis demonstrate an increased tissue level of </span>connective tissue growth factor (CTGF; 25-fold) and </span>transforming growth factor (TGF-B</span><sub>1</sub>; increased in 50% of chronic pancreatitis tissue samples). CTGF is a cysteine-rich peptide that belongs to a family of genes needed for the coordination of tissue repair.<span><span><sup>15</sup></span></span> The overexpression of CTGF and TGF-B<sub>1</sub> in chronic pancreatitis suggests that these proteins may contribute to the enhanced extracellular matrix synthesis, leading to fibrin and collagen deposition in chronic pancreatitis.<span><span><sup>15</sup></span></span><span> As a result of pancreatic fibrosis, complications that develop include:\\n\\t\\t\\t\\t</span><ul><li><span></span><span><div><div><span>Bile duct obstruction (from cicatrix or a mass in the head of the pancreas)</span></div><figure><span><img><ol><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span><span><span><p><span>Figure 4</span>. <!-->An endoscopic retrograde cholangiopancreatography (ERCP) showing a dilated bile duct (BD) and pancreatic duct (PD).</p></span></span></figure><figure><span><img><ol><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span><span><span><p><span>Figure 5</span>. <!-->The author's approach to all pancreatic surgery begins with an upper midline incision. The incision in this case was 3 inches long. (See also Color Plate 1, <span><span>Fig. 1.)</span></span></p></span></span></figure></div></span></li><li><span></span><span><div>Duodenal obstruction (from extrinsic compression of a fibrosed pancreas)</div></span></li><li><span></span><span><div><span>Gastric varices (from </span>splenic vein entrapment and obstruction)</div></span></li><li><span></span><span><div>Obstruction of the pancreatic duct (from calculi, fibrotic parenchymal strictures, or duct strictures)</div></span></li><li><span></span><span><div>Pancreatic ascites (from a leaking pancreatic duct or pseudocyst)</div></span></li><li><span></span><span><div>Pancreatic pseudocyst formation (discussed elsewhere in this issue)</div></span></li></ul></div></div>\",\"PeriodicalId\":54441,\"journal\":{\"name\":\"Surgical Clinics of North America\",\"volume\":\"81 2\",\"pages\":\"Pages 431-455\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2001-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical Clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0039610905701316\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2005/7/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039610905701316","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2005/7/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

慢性胰腺炎的特点是不可逆的和持续的破坏胰腺腺泡和导管细胞。这些细胞被纤维组织和细胞外基质的沉积所取代慢性胰腺炎是一种疾病,范围从轻度,偶尔发作;至中度,发作频繁,腺体变化更不可逆;直至严重,伴有致残后遗症,如顽固性疼痛、糖尿病和胰腺功能不全(图1)。直到最近,外科医生只推荐患有严重慢性胰腺炎的患者,这些患者营养不良,经常滥用酒精或麻醉剂,并且患有终末期腺体疾病。手术后胰腺功能没有改善,疼痛的改善和发作频率和严重程度的减少是手术成功的唯一决定因素。过去十年发生了很大的变化。今天,通过内窥镜和轴向成像早期诊断慢性胰腺炎,并对轻微症状进行干预,可能会延缓分泌功能的进行性变化以及外分泌和内分泌功能障碍。40,42慢性胰腺炎的客观并发症需要手术治疗;然而,目前,这些方法只占治疗慢性胰腺炎的一小部分。相比之下,手术最常见的适应症是难以处理、生活方式受到干扰和疼痛等主观主诉。这些问题造成了选择治疗程序和患者的两难境地,类似于决定陪审团对疼痛和痛苦的奖励。在这两种情况下,都很难做出明智的判断或得到愉快的结果。本文综述了目前慢性胰腺炎的外科治疗方法。从25年的经验中吸取的教训告诫外科医生,肆无忌惮的热情最好被温和的判断所取代。慢性胰腺炎(与胰腺癌一样)的患病率很低,每10万人中有8至10例。全球75%的患者因长期饮酒而患病。原发性胆管阻塞作为慢性胰腺炎的病因,仅在5%的患者中存在根据医院人口和外科转诊实践,胰腺炎的病因差别很大。特发性胰腺炎是一种排他性诊断,在三级中心比在城市医院更常见,占到作者所在机构转诊病例的近40%。慢性胰腺炎的病因是重要的,只有在防止正在进行的腺体损伤,消除外源性刺激,如果确定。手术方式的选择取决于解剖结果,而不是病因。慢性胰腺炎的并发症继发于胰腺的愈合和纤维化或胰管中密集的蛋白物质沉积,导致胰管阻塞和结石。接受胰腺切除术的慢性胰腺炎患者的组织样本显示结缔组织生长因子(CTGF;25倍)和转化生长因子(TGF-B1;在50%的慢性胰腺炎组织样本中增加)。CTGF是一种富含半胱氨酸的肽,属于协调组织修复所需的基因家族慢性胰腺炎中CTGF和TGF-B1的过表达表明,这些蛋白可能有助于增强细胞外基质合成,导致慢性胰腺炎中纤维蛋白和胶原沉积胰腺纤维化导致的并发症包括:胆管梗阻(由瘢痕或胰腺头部肿块引起)。内镜逆行胆管造影(ERCP)显示胆管(BD)和胰管(PD)扩张。下载:下载完整尺寸的图像图5。作者对所有胰腺手术的方法从上中线切口开始。这个病例的切口有3英寸长。(另见图1色板1)十二指肠梗阻(由纤维化胰腺外源性压迫引起)胃静脉曲张(由脾静脉夹闭和梗阻引起)胰管梗阻(由结石、纤维化实质狭窄或胰管狭窄引起)胰腹水(由胰管渗漏或假性囊肿引起)胰假性囊肿形成(在本问题的其他地方讨论)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Surgery and Chronic Pancreatitis
Chronic pancreatitis is characterized by irreversible and continued destruction of pancreatic acinar and duct cells. These cells are replaced by fibrous tissue and deposition of extracellular matrix.15 Chronic pancreatitis is a spectrum of a disease that ranges from mild, with occasional attacks; to moderate, with frequent attacks and more irreversible glandular changes; to severe, with disabling sequelae, such as intractable pain, diabetes, and pancreatic insufficiency (Fig. 1). Until recently, surgeons were referred only patients with severe chronic pancreatitis who were malnourished, often abusers of alcohol or narcotics, and who had end-stage glandular disease. Pancreatic function did not improve after surgery, and improvement of pain and diminished frequency and severity of attacks were the sole determinant of a successful surgical procedure. Much has changed in the past decade. Today, earlier diagnosis of chronic pancreatitis by endoscopy and axial imaging and intervention for mild symptoms may delay the progressive changes in secretory function and exocrine and endocrine malfunction.40, 42
Objective complications of chronic pancreatitis warrant surgery; however, at present, these account for a minority of the procedures used to treat chronic pancreatitis. In contrast, the most common indications for surgery are the subjective complaints of intractability, interference with lifestyle, and pain. These issues create a dilemma in the selection of procedures and patients for treatment, akin to deciding jury awards for pain and suffering. In both, it is difficult to reach a wise judgment or a happy outcome.
This article reviews the current surgical treatment of chronic pancreatitis. Lessons learned from a 25-year experience are included to caution surgeons that unbridled enthusiasm is best replaced by tempered judgments.
The prevalence of chronic pancreatitis (as with pancreatic cancer) is low, at 8 to 10 cases per 100,000 population. Long-term consumption of alcohol is the cause of the disease in 75% of patients worldwide. Primary duct obstruction as a cause of chronic pancreatitis is present in only 5% of patients.42 Depending on hospital population and surgical referral practice, the causes of pancreatitis vary widely. Idiopathic pancreatitis, a diagnosis of exclusion, is more common in tertiary centers than in urban hospitals and accounts for nearly 40% of the cases referred to the author's institution. The cause of chronic pancreatitis is important only in preventing ongoing glandular insult by removing an exogenous stimulus, if identified. The choice of surgical procedure is dependent on anatomic findings and not on the cause.
Complications of chronic pancreatitis occur secondary to healing and fibrosis of the pancreas or deposition of inspissated proteinaceous material in the pancreatic duct, leading to duct obstruction and calculi. Tissue samples from patients undergoing pancreatic resection for chronic pancreatitis demonstrate an increased tissue level of connective tissue growth factor (CTGF; 25-fold) and transforming growth factor (TGF-B1; increased in 50% of chronic pancreatitis tissue samples). CTGF is a cysteine-rich peptide that belongs to a family of genes needed for the coordination of tissue repair.15 The overexpression of CTGF and TGF-B1 in chronic pancreatitis suggests that these proteins may contribute to the enhanced extracellular matrix synthesis, leading to fibrin and collagen deposition in chronic pancreatitis.15 As a result of pancreatic fibrosis, complications that develop include:
  • Bile duct obstruction (from cicatrix or a mass in the head of the pancreas)
    1. Download: Download full-size image

    Figure 4. An endoscopic retrograde cholangiopancreatography (ERCP) showing a dilated bile duct (BD) and pancreatic duct (PD).

    1. Download: Download full-size image

    Figure 5. The author's approach to all pancreatic surgery begins with an upper midline incision. The incision in this case was 3 inches long. (See also Color Plate 1, Fig. 1.)

  • Duodenal obstruction (from extrinsic compression of a fibrosed pancreas)
  • Gastric varices (from splenic vein entrapment and obstruction)
  • Obstruction of the pancreatic duct (from calculi, fibrotic parenchymal strictures, or duct strictures)
  • Pancreatic ascites (from a leaking pancreatic duct or pseudocyst)
  • Pancreatic pseudocyst formation (discussed elsewhere in this issue)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
129
审稿时长
6-12 weeks
期刊介绍: Surgical Clinics of North America has kept surgeons informed on the latest techniques from leading surgical centers worldwide. Each bimonthly issue (February, April, June, August, October, and December) is devoted to a single topic relevant to the busy surgeon, with articles written by experts in the field. Case studies and complete references are also included to give you the most thorough data you need to stay on top of your practice. Topics include general surgery, alimentary surgery, abdominal surgery, critical care surgery, trauma surgery, endocrine surgery, breast cancer surgery, transplantation, pediatric surgery, and vascular surgery.
期刊最新文献
Contents Copyright Contributors Forthcoming Issues From the Scalpel to Recovery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1